Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly diagnosed advanced-stage epithelial ovarian cancer: the AdORN study.

Gynecologic oncology·2026
Same author

Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Gynecologic oncology·2026
Same author

Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer.

Gynecologic oncology·2026
Same author

Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular Profile.

Practical radiation oncology·2026

Related Experiment Video

Updated: May 11, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Image-guided brachytherapy for gynecologic surgeons.

Junzo Chino1, Angeles Alvarez Secord

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. junzo.chino@duke.edu

Surgical Oncology Clinics of North America
|April 30, 2013
PubMed
Summary
This summary is machine-generated.

Brachytherapy for gynecologic cancers is improving with volume-based dose, moving beyond plain radiographs for better patient anatomy correlation and outcomes. This review highlights advances in cervical cancer treatment.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Related Experiment Videos

Last Updated: May 11, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Area of Science:

  • Oncology
  • Radiation Oncology
  • Gynecologic Oncology

Background:

  • Brachytherapy is crucial for advanced gynecologic cancers, particularly uterine and cervical.
  • Traditional dose specification relies on plain radiographs, lacking anatomical correlation.
  • This limits precise radiation delivery and outcome optimization.

Purpose of the Study:

  • To review advances in brachytherapy dose specification for gynecologic malignancies.
  • To highlight the transition from point-based to volume-based dose planning.
  • To use cervical cancer as a model for these advancements.

Main Methods:

  • Review of recent literature on brachytherapy techniques in gynecologic oncology.
  • Analysis of the shift towards image-guided and volume-based dose planning.
  • Focus on cervical cancer treatment as a representative case.

Main Results:

  • Volume-based dose specification improves correlation with patient anatomy and disease extent.
  • Advanced techniques allow for more precise radiation delivery, sparing normal tissues.
  • Improved outcomes are associated with customized, volume-based brachytherapy.

Conclusions:

  • Volume-based dose specification represents a significant advancement in brachytherapy for gynecologic cancers.
  • Further research and adoption of these techniques promise enhanced treatment efficacy.
  • Future directions involve integrating these advanced methods for optimal patient care.